Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of estrogen receptor (ER), progesterone receptor (PR) expression, and of epidermal growth factor receptor 2 (ERBB2) gene amplification. This evidence concerns the gene PGR and triple-negative breast carcinoma.